Quick Answer
Rallybio Corp reported Total Assets of $62.26 million for the year ending 2025.
- Rallybio Corp showed a decrease of -8.6% in Total Assets from 2024 to 2025.
- This data is from Rallybio Corp's annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $120.10 million | Q3 2021: $193.87 million | Q1 2022: $169.35 million | Q2 2022: $155.61 million | Q3 2022: $143.67 million | Q1 2023: $162.32 million | Q2 2023: $147.58 million | Q3 2023: $133.19 million | Q1 2024: $99.36 million | Q2 2024: $92.43 million | Q3 2024: $79.01 million | Q1 2025: $57.98 million | Q2 2025: $51.00 million | Q3 2025: $67.66 million.
- Over the full 6 years of available data (2020 to 2025), Rallybio Corp's Total Assets has declined by 56.1%.
- Historical annual values: Fiscal year 2025: $62.26 million | Fiscal year 2024: $68.11 million | Fiscal year 2023: $115.62 million | Fiscal year 2022: $180.44 million | Fiscal year 2021: $182.19 million | Fiscal year 2020: $141.86 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: